Trial Profile
A Phase II Study of CCI-779 [temsirolimus] in Previously Treated Patients With Mantle Cell Non-Hodgkin's Lymphoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2013
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 07 Sep 2005 New trial record.